**Core Concept**
The question requires knowledge of antimalarial drugs and their safety during pregnancy, focusing on the pharmacological principles of teratogenicity and fetal protection. **Malaria** in pregnancy poses significant risks, and the choice of antimalarial is critical.

**Why the Correct Answer is Right**
Given the options are missing, a general approach is that **Chloroquine** is often considered safe for use during pregnancy, especially for areas without **Chloroquine-resistant Plasmodium** strains. Its safety profile, particularly in the first trimester, is more established compared to other antimalarials.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, a common incorrect choice might be **Mefloquine**, which, while sometimes used in pregnancy, has a more cautious approach due to potential side effects.
**Option B:** Another incorrect option could be **Doxycycline**, which is contraindicated in pregnancy due to the risk of inhibiting bone growth and causing tooth discoloration in the fetus.
**Option C:** An incorrect choice might be **Atovaquone-Proguanil**, which, although used in some cases during pregnancy, is not typically the first-line treatment due to limited data on its safety compared to older drugs.
**Option D:** Without the specific option, **Artemisinin** derivatives are generally avoided in the first trimester due to concerns about teratogenic effects, making them an unlikely safest choice.

**Clinical Pearl / High-Yield Fact**
It's crucial to remember that the safety of antimalarial drugs can vary by trimester and the specific drug in question. Always consult current guidelines for the most up-to-date recommendations on managing malaria in pregnant women.

**Correct Answer:** Correct Answer: C. Chloroquine.